TGFB2 and neoplasm: Our present study shows that high levels of TGFB2 expression in combination with low levels of markers of antigen-presenting cells resulted in worse OS outcomes in 45 pbDMG patients (Figures S1 and S2), as extended from our previously conducted study assessing the importance of increased levels of transforming growth factor TGFB2 in tumor tissues of 41 children with pbDMGs [3].